| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059885A1 Therapeutic acridone and acridine compounds |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059866A1 Geranyl compounds |
| 07/24/2003 | WO2003059855A1 Synthesis of combretastatin a-2 prodrugs |
| 07/24/2003 | WO2003059395A2 Antisense compounds directed against human csf-1 |
| 07/24/2003 | WO2003059379A2 Immunogenic carcinoembryonic antigen (cea) |
| 07/24/2003 | WO2003059361A1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium |
| 07/24/2003 | WO2003059355A1 Quinazolinone compounds in combined modalities for improved cancer treatment |
| 07/24/2003 | WO2003059354A2 Anti-angiogenesis combination therapies comprising pyridazine or pyridine derivatives |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003059323A2 Stable salts of o-acetylsalicylic acid containing basic amino acids ii |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059273A2 Antibody-avidin fusion proteins as cytotoxic drugs |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059255A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 07/24/2003 | WO2003059148A2 Gene expression profiles in stomach cancer |
| 07/24/2003 | WO2003048168A3 Trioxane derivatives as antimalaria or anticancer compounds |
| 07/24/2003 | WO2003045999A3 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 07/24/2003 | WO2003018612A3 Extracellular messengers |
| 07/24/2003 | WO2003011895A3 Compositions and methods for modulation of immune responses |
| 07/24/2003 | WO2003011221A3 PREPARATION AND USE OF α-KETO PHOSPHONATES |
| 07/24/2003 | WO2003006688A3 Methods for diagnosis and treatment of diseases associated with altered expression of gnas |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2003004526B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or resistance to viruses and their use as medicines |
| 07/24/2003 | WO2002100325A3 Polyvalent nanoparticles |
| 07/24/2003 | WO2002099057A3 Sams modifiers of the p53 pathway and methods of use |
| 07/24/2003 | WO2002094873A3 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use |
| 07/24/2003 | WO2002088358A3 Human fibroblast growth factor-related compositions |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002059323A3 Aminoacyl trna synthetases |
| 07/24/2003 | WO2002053770A3 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/24/2003 | WO2002052018A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/24/2003 | WO2002044417A3 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 07/24/2003 | WO2002042272A3 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | WO2002022687A3 Viral chemokine-tumur antigen fusion proteins |
| 07/24/2003 | WO2002003979A3 Combination of 2-methoxyestradiol and an agent that increases intracellular superoxide anion |
| 07/24/2003 | US20030139687 Noninvasive measurement of chemical substances |
| 07/24/2003 | US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139585 Oligonucleotide derivatives which are at least partly double-stranded and which have a 2'5'-linked oligonucleotide residue on at least one 3' end; use in formulating pharmaceutical for tumor therapy, infectious diseases |
| 07/24/2003 | US20030139584 Tumor necrosis factor Receptor-Associated Factor (TRAF) protein-interacting hereditary multiple extoses (TREX) for use in the diagnosis and treatment of cancer and autoimmune disorders; antitummor agents |
| 07/24/2003 | US20030139463 Anticancer agents; antiarthritic agents |
| 07/24/2003 | US20030139460 Antitumor, anticancer agents; antiinflammatory agents; psoriasis; antiarthritic agents; side effect reduction |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139428 Purine derivatives for treatment of gastrointestinal disorders, immunological disorders, neurological disorders |
| 07/24/2003 | US20030139416 Anticancer agents; kidney disease |
| 07/24/2003 | US20030139414 Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139401 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139398 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/24/2003 | US20030139394 Dibenzodiazepine derivatives, their preparation and use |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139379 Autoimmune disease, osteoporosis, rheumatic diseases, skin disorders |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139374 Combined methods for tumor vasculature coagulation and treatment |
| 07/24/2003 | US20030139373 Method for cancer therapy |
| 07/24/2003 | US20030139372 Modulation of bone formation |
| 07/24/2003 | US20030139365 Expression and export of angiogenesis inhibitors as immunofusins |
| 07/24/2003 | US20030139364 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139352 Atp binding cassette drug transporter; antitumor agents; thgerapy for drug resistance |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030139345 Synthetic peptides and methods for treating cancer invasion and metastasis |
| 07/24/2003 | US20030139334 Cell cycle controlling protein; vaccines |
| 07/24/2003 | US20030139330 Transcription factors containing two potential dna binding motifs |
| 07/24/2003 | US20030139325 Complex comprising OCIF and polysaccharide |
| 07/24/2003 | US20030139323 Preradiation therapy; side effect reduction |
| 07/24/2003 | US20030138946 Genetically engineered major histocompatibiity complex antigen presenting cells for activating CD8 lymphocytes and producing cytokines and becoming cytotoxic; antitumor agents |
| 07/24/2003 | US20030138931 Hydrolase polypeptide for dephosphorylating mitogen activated kinases (MAP-kinase); antiapoptosis; antiproliferative agents |
| 07/24/2003 | US20030138926 Novel polynucleotides and polypeptides encoded thereby |
| 07/24/2003 | US20030138884 APRIL- a novel protein with growth effects |
| 07/24/2003 | US20030138864 Comparing expression levels of genes or proteins in human tissue or cells from normal and tumor origin, selecting enzyme of which mRNA or protein levels in tumor tissue are higher by two-fold as compared to normal cells or tissue |
| 07/24/2003 | US20030138854 Method for determining BAGE expression |
| 07/24/2003 | US20030138839 Polypeptide comprising ubiquitination regulating domain; antiproliferative agents; neuroprotectants; cancer diagnosis |
| 07/24/2003 | US20030138833 Psoriasin expression by breast epithelial cells |
| 07/24/2003 | US20030138793 Kit for identifying the origin of tumors in prostate, breast, colorectal, lung, ovarian, gastroesophageal, pancreatic, liver, kidney or bladder cells by way of probes for analyzing marker gene expression |
| 07/24/2003 | US20030138493 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 07/24/2003 | US20030138481 Liposomes |